Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer

Recruiting now

Conditions studied: Cancer

In brief

Prospective observational study of a precision medicine approach in patients with advanced cancer. In this registrational study, patients with advanced cancer undergoing extensive molecular sequencing within the precision oncology program of Charité University Medicine, Berlin will be registered and followed to assess the efficacy of the program and assess the clinical relevance and frequency of molecular alterations, individualized therapies and novel molecular analysis tools.

Key facts

Study ID

NCT05926284

Run by

Charite University, Berlin, Germany

People needed

2000

Starts

2016-03-01

Expected to finish

2031-03-01

Last updated by the study team

2023-07-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• advanced cancer
• ability to give written informed consent
• performance status allows initiation of a potential targeted treatment after molecular analysis
• molecular analysis has been done or planned

You may not qualify if…

• unable to give written informed consent

Where it is running

• Charité Comprehensive Cancer Center — Berlin, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.